NEW YORK (GenomeWeb) – Pressure Biosciences reported on Wednesday that its total fourth quarter revenues in 2016 rose 15 percent, as an increase in products and services revenues was softened by a decrease in grant revenues.

For the three months ended Dec. 31, 2016 the lab instruments and consumables manufacturer reported revenues of $419,711, up from $364,119 a year earlier.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.